DOT 125 PREMIX COCCIDIOSTAT FOR POULTRY

Main information

  • Trade name:
  • DOT 125 PREMIX COCCIDIOSTAT FOR POULTRY
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • DOT 125 PREMIX COCCIDIOSTAT FOR POULTRY
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • POULTRY | POULTRY BROILERS (MEAT FOR HUMAN CONSUM) | POULTRY PULLETS (GROWING CHOOK) | TURKEYS | BREEDER | BREEDERS | BREEDING P
  • Therapeutic area:
  • ANTIBIOTIC & RELATED
  • Therapeutic indications:
  • COCCIDIOSIS | EIMERIA ACERVULINA | EIMERIA BRUNETTI | EIMERIA MAXIMA | EIMERIA MIVATI | EIMERIA NECATRIX | EIMERIA TENELLA

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Stopped
  • Authorization number:
  • 35534
  • Last update:
  • 09-08-2016

16-1-2019

Safety and efficacy of B‐Act® (Bacillus licheniformis DSM 28710) as a feed additive for turkeys for fattening, turkeys reared for breeding and minor poultry species for fattening or raised for laying

Safety and efficacy of B‐Act® (Bacillus licheniformis DSM 28710) as a feed additive for turkeys for fattening, turkeys reared for breeding and minor poultry species for fattening or raised for laying

Published on: Mon, 14 Jan 2019 Following a request from the European Commission, the EFSA Panel on Additives and Products or Substances used in Animal Feed was asked to deliver a scientific opinion on the safety and efficacy of B‐Act® when used in feed for turkeys for fattening, reared for breeding and minor poultry species for fattening or raised for laying. B‐Act® is a preparation containing viable spores of a Bacillus licheniformis strain. This species is considered by EFSA to be suitable for the qua...

Europe - EFSA - European Food Safety Authority EFSA Journal

There are no news related to this product.